New Penn-Designed Gel Allows for Targeted Therapy After Heart Attack

Combatting the tissue degrading enzymes that cause lasting damage following a heart attack is tricky. Each patient responds to a heart attack differently and damage can vary from one part of the heart muscle to another, but existing treatments can’t be fine-tuned to deal with this variation. 

Frontiers On-Demand Drug Delivery: Recent Advances in Cardiovascular Applications

A New Era of Cardiac Cell Therapy: Opportunities and Challenges - Huang - 2019 - Advanced Healthcare Materials - Wiley Online Library

Recent Developments in Cardiovascular Stem Cells

Heterotrimeric G Proteins as Therapeutic Targets in Drug Discovery

Targeting miR-30d reverses pathological cardiac hypertrophy - eBioMedicine

E-selectin Targeting PEGylated-thioaptamer Prevents Breast Cancer Metastases: Molecular Therapy - Nucleic Acids

Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype

RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs

Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma

Advances in Injectable Hydrogel Strategies for Heart Failure Treatment - He - 2023 - Advanced Healthcare Materials - Wiley Online Library

Molecules, Free Full-Text

Novel Dual CAR T Cell Immunotherapy Holds Promise for Targeting the HIV Reservoir

Factors Influencing Retention of Injected Biomaterials to Treat Myocardial Infarction - Schotman - 2022 - Advanced Materials Interfaces - Wiley Online Library

Advances and challenges in adeno-associated viral inner-ear gene therapy for sensorineural hearing loss: Molecular Therapy Methods & Clinical Development